<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3692545&amp;fmt=gif">

A wake-up call for America: Fentanyl and the unique challenges the synthetic pill poses to the U.S.

Michael Brown
Michael Brown
Michael W. Brown is the global director of counter-narcotics technology at Rigaku Analytical Devices. He has a distinguished career spanning more than 32 years as a Special Agent for the Drug Enforcement Administration (DEA). Most recently he was the DEA Headquarters staff coordinator for the Office of Foreign Operations for the Middle East-Europe-Afghanistan-India. Prior to that he served as the country attaché in India and Myanmar providing foreign advisory support for counter narcotic enforcement. He also spent 10 years in Pakistan as a special advisor to the US Embassy on various law enforcement issues. Michael is a graduate of the United States Ranger Training Battalion and has a master’s degree in Interdisciplinary Technology and Management from the University of Eastern Michigan.
    

This interview first appeared on Fox 2 Detroit

TV Interview March 2, 2023 - Michael Brown, Rigaku Analytical Devices' global director of counter-narcotics technology, recently sat down with Deena Centofanti of Fox 2 Detroit, a regional news network with a focus on health topics, to discuss the unique challenges fentanyl poses to the U.S. population.

 

Be sure to check out Michael's podcast 'The Opioid Matrix,' where he has a 360 degree discussion with all angles contributing to the current opioid crisis our communities face.

Opioid_Matrix_Cover_Art